TNFα Increases the Expression of β2 Adrenergic Receptors in Osteoblasts
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Tumor necrosis factor alpha (TNFα) is a multifunctional cytokine that is elevated in inflammatory diseases such as atherosclerosis, diabetes and rheumatoid arthritis. Recent evidence has suggested that β2 adrenergic receptor (β2AR)activation in osteoblasts suppresses osteogenic activity. In the present study, we explored whether TNFα modulates βAR expression in osteoblastic cells and whether this regulation is associated with the inhibition of osteoblast differentiation by TNFα. In the experiments, we used C2C12 cells, MC3T3-E1 cells and primary cultured mouse bone marrow stromal cells. Among the three subtypes of βAR, β2 and β3AR were found in our analysis to be upregulated by TNFα. Moreover,isoproterenol-induced cAMP production was observed to be significantly enhanced in TNFα-primed C2C12 cells, indicating that TNFα enhances β2AR signaling in osteoblasts. TNFα was further found in C2C12 cells to suppress bone morphogenetic protein 2-induced alkaline phosphatase (ALP) activity and the expression of osteogenic marker genes including Runx2, ALP and osteocalcin. Propranolol, a β2AR antagonist, attenuated this TNFα suppression of osteogenic differentiation. TNFα increased the expression of receptor activator of NF-κB ligand (RANKL), an essential osteoclastogenic factor, in C2C12 cells which was again blocked by propranolol. In summary, our data show that TNFα increases β2AR expression in osteoblasts and that a blockade of β2AR attenuates the suppression of osteogenic differentiation and stimulation of RANKL expression by TNFα. These findings imply that a crosstalk between TNFαand β2AR signaling pathways might occur in osteoblasts to modulate their function.
Abstract
Tumor necrosis factor alpha (TNFα) is a multifunctional cytokine that is elevated in inflammatory diseases such as atherosclerosis, diabetes and rheumatoid arthritis. Recent evidence has suggested that β2 adrenergic receptor (β2AR)activation in osteoblasts suppresses osteogenic activity. In the present study, we explored whether TNFα modulates βAR expression in osteoblastic cells and whether this regulation is associated with the inhibition of osteoblast differentiation by TNFα. In the experiments, we used C2C12 cells, MC3T3-E1 cells and primary cultured mouse bone marrow stromal cells. Among the three subtypes of βAR, β2 and β3AR were found in our analysis to be upregulated by TNFα. Moreover,isoproterenol-induced cAMP production was observed to be significantly enhanced in TNFα-primed C2C12 cells, indicating that TNFα enhances β2AR signaling in osteoblasts. TNFα was further found in C2C12 cells to suppress bone morphogenetic protein 2-induced alkaline phosphatase (ALP) activity and the expression of osteogenic marker genes including Runx2, ALP and osteocalcin. Propranolol, a β2AR antagonist, attenuated this TNFα suppression of osteogenic differentiation. TNFα increased the expression of receptor activator of NF-κB ligand (RANKL), an essential osteoclastogenic factor, in C2C12 cells which was again blocked by propranolol. In summary, our data show that TNFα increases β2AR expression in osteoblasts and that a blockade of β2AR attenuates the suppression of osteogenic differentiation and stimulation of RANKL expression by TNFα. These findings imply that a crosstalk between TNFαand β2AR signaling pathways might occur in osteoblasts to modulate their function.
참고문헌 (23)
- Bonnet N, "Low dose beta-blocker prevents ovariectomy-induced bone loss in rats without affecting heart functions", J Cell Physiol, 217, pp.819~827 (2008)
- Collins S, "Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL", 6J ob, Mol Endocrinol, pp.1994, 8[DOI]
- Cope AP, "Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling", J Exp Med, 185, pp.1573~1584 (1997)
- El Hadri K, "Developmental expression and functional activity of beta 1- and beta 3-adrenoceptors in murine 3T3-F442A differentiating adipocytes", Eur J Pharmacol, 297, pp.107~119 (1996)
- Elefteriou F, "Leptin regulation of bone resorption by the sympathetic nervous system and CART", Nature, 434, pp.514~520 (2005)
- Feve B, "Atypical beta-adrenergic receptor in 3T3-F442A adipocytes. Pharmacological and molecular relationship with the human beta 3-adrenergic receptor", J Biol Chem, 266, pp.20329~20336 (1991)
- Fu L, "The molecular clock mediates leptin-regulated bone formation", Cell, 122, pp.803~815 (2005)
- Granneman JG, "Analysis of human and rodent beta 3-adrenergic receptor messenger ribonucleic acids", Endocrinology, 135, pp.1025~1031 (1994)
- Hadri KE, "Differential regulation by tumor necrosis factor-alpha of beta1-, beta2-, and beta3-adrenoreceptor gene expression in 3T3-F442A adipocytes", J Biol Chem, 272, pp.24514~24521 (1997)
- Kim SN, "Effect of Osteotropic Agents on the Expression of RANKL and OPG in Saos-2 Cells", Int J Oral Biol, 27, pp.15~21 (2002)
- Lacey DL, "Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation", Cell, 93, pp.165~176 (1998)
- Lee CW, "TNF-alpha induces MMP-9 expression via activation of Src", EGFR, PDGFR, Akt cascade and promotion of NF-kappaB, pp.p300 binding in human tracheal smooth muscle cells, American journal of physiology Lung cellular and molecular physiology[DOI]
- Hye-Lim Lee, "Msx2 mediates the inhibitory action of TNF-α on osteoblast differentiation", Experimental and Molecular Medicine, 42(6), pp.437~445 (2010), 생화학분자생물학회
- Maini RN, "The role of cytokines in rheumatoid arthritis. The Croonian Lecture 1995", J R Coll Physicians Lond, 30, pp.344~351 (1996)
- McMahon MS, "Does anti-TNF-alpha have a role in the treatment of osteoporosis", Bull NYU Hosp Jt Dis, 66, pp.280~281 (2008)
- Navarro-Gonzalez JF, "Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy", Cytokine Growth Factor Rev, 20, pp.165~173 (2009)
- Romas E, "Involvement of receptor activator of NFkappaB ligand and tumor necrosis factoralpha in bone destruction in rheumatoid arthritis", Bone, 30, pp.340~346 (2002)
- Sato T, "Effects of propranolol on bone metabolism in spontaneously hypertensive rats", J Pharmacol Exp Ther, 334, pp.99~105 (2010)
- Stern L, "Synergistic regulation of pulmonary betaadrenergic receptors by glucocorticoids and interleukin-1", J Biol Chem, 263, pp.15876~15879 (1988)
- Takeda S, "Leptin regulates bone formation via the sympathetic nervous system", Cell, 111, pp.305~317 (2002)
- Togari A, "Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption", J Pharmacol Sci, 106, pp.542~546 (2008)
- Yi T, "Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling", JOURNAL OF CELLULAR PHYSIOLOGY, 217(2), pp.409~422, WILEY-LISS
- Zhang YH, "Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways", J Biol Chem, 276, pp.563~568 (2001)